APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bradykinin Receptor Antagonists

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bradykinin Receptor Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025189 pages

Choose your research edition.

Industry ResearchBradykinin Receptor Antagonists Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Bradykinin Receptor Antagonists Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Bradykinin Receptor Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bradykinin Receptor Antagonists Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Bradykinin Receptor Antagonists Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Bradykinin Receptor Antagonists market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bradykinin Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bradykinin Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bradykinin Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bradykinin Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bradykinin Receptor Antagonists include Takeda Pharmaceuticals, Sandoz, Jiangsu Hengrui Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy, Glenmark Pharmaceuticals, Fresenius Kabi, Eugia Pharma Specialities and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bradykinin Receptor Antagonists market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bradykinin Receptor Antagonists and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bradykinin Receptor Antagonists sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bradykinin Receptor Antagonists market size, projected growth trends, production technologies, key applications, and end-use industries.

Bradykinin Receptor Antagonists Segment by Company

Takeda Pharmaceuticals

Sandoz

Jiangsu Hengrui Pharmaceuticals

Chengdu Shengnuo Biology Pharmacy

Glenmark Pharmaceuticals

Fresenius Kabi

Eugia Pharma Specialities

Cipla

Bradykinin Receptor Antagonists Segment by Type

Icatibant

Other

Bradykinin Receptor Antagonists Segment by Application

Hospital and Clinic

Pharmacy

Other

Bradykinin Receptor Antagonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bradykinin Receptor Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bradykinin Receptor Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bradykinin Receptor Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bradykinin Receptor Antagonists market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bradykinin Receptor Antagonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bradykinin Receptor Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bradykinin Receptor Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bradykinin Receptor Antagonists Industry Trends Table 2. Bradykinin Receptor Antagonists Industry Drivers Table 3. Bradykinin Receptor Antagonists Industry Opportunities and Challenges Table 4. Bradykinin Receptor Antagonists Industry Restraints Table 5. Global Bradykinin Receptor Antagonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bradykinin Receptor Antagonists Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bradykinin Receptor Antagonists Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Bradykinin Receptor Antagonists Sales Market Share by Manufacturers Table 9. Global Bradykinin Receptor Antagonists Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Bradykinin Receptor Antagonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bradykinin Receptor Antagonists Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bradykinin Receptor Antagonists Manufacturers, Product Type & Application Table 13. Global Bradykinin Receptor Antagonists Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bradykinin Receptor Antagonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Icatibant Table 17. Major Manufacturers of Other Table 18. Global Bradykinin Receptor Antagonists Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Bradykinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 20. Global Bradykinin Receptor Antagonists Sales by Type (2027-2032) & (K Units) Table 21. Global Bradykinin Receptor Antagonists Sales Market Share by Type (2021-2026) Table 22. Global Bradykinin Receptor Antagonists Sales Market Share by Type (2027-2032) Table 23. Global Bradykinin Receptor Antagonists Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Bradykinin Receptor Antagonists Revenue by Type (2021-2026) & (K Units) Table 25. Global Bradykinin Receptor Antagonists Revenue by Type (2027-2032) & (K Units) Table 26. Global Bradykinin Receptor Antagonists Revenue Market Share by Type (2021-2026) Table 27. Global Bradykinin Receptor Antagonists Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Pharmacy Table 30. Major Manufacturers of Other Table 31. Global Bradykinin Receptor Antagonists Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Bradykinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 33. Global Bradykinin Receptor Antagonists Sales by Application (2027-2032) & (K Units) Table 34. Global Bradykinin Receptor Antagonists Sales Market Share by Application (2021-2026) Table 35. Global Bradykinin Receptor Antagonists Sales Market Share by Application (2027-2032) Table 36. Global Bradykinin Receptor Antagonists Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Bradykinin Receptor Antagonists Revenue by Application (2021-2026) & (K Units) Table 38. Global Bradykinin Receptor Antagonists Revenue by Application (2027-2032) & (K Units) Table 39. Global Bradykinin Receptor Antagonists Revenue Market Share by Application (2021-2026) Table 40. Global Bradykinin Receptor Antagonists Revenue Market Share by Application (2027-2032) Table 41. Global Bradykinin Receptor Antagonists Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Bradykinin Receptor Antagonists Sales by Region (2021-2026) & (K Units) Table 43. Global Bradykinin Receptor Antagonists Sales Market Share by Region (2021-2026) Table 44. Global Bradykinin Receptor Antagonists Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Bradykinin Receptor Antagonists Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Bradykinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Bradykinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 48. North America Bradykinin Receptor Antagonists Sales by Country (2027-2032) & (K Units) Table 49. Europe Bradykinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Bradykinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 51. Europe Bradykinin Receptor Antagonists Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Bradykinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Bradykinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Bradykinin Receptor Antagonists Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Bradykinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Bradykinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Bradykinin Receptor Antagonists Sales by Country (2027-2032) & (K Units) Table 58. Global Bradykinin Receptor Antagonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Bradykinin Receptor Antagonists Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Bradykinin Receptor Antagonists Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Bradykinin Receptor Antagonists Revenue Market Share by Region (2021-2026) Table 62. Global Bradykinin Receptor Antagonists Revenue Market Share by Region (2027-2032) Table 63. Takeda Pharmaceuticals Company Information Table 64. Takeda Pharmaceuticals Business Overview Table 65. Takeda Pharmaceuticals Bradykinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Takeda Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio Table 67. Takeda Pharmaceuticals Recent Development Table 68. Sandoz Company Information Table 69. Sandoz Business Overview Table 70. Sandoz Bradykinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sandoz Bradykinin Receptor Antagonists Product Portfolio Table 72. Sandoz Recent Development Table 73. Jiangsu Hengrui Pharmaceuticals Company Information Table 74. Jiangsu Hengrui Pharmaceuticals Business Overview Table 75. Jiangsu Hengrui Pharmaceuticals Bradykinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Jiangsu Hengrui Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio Table 77. Jiangsu Hengrui Pharmaceuticals Recent Development Table 78. Chengdu Shengnuo Biology Pharmacy Company Information Table 79. Chengdu Shengnuo Biology Pharmacy Business Overview Table 80. Chengdu Shengnuo Biology Pharmacy Bradykinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Chengdu Shengnuo Biology Pharmacy Bradykinin Receptor Antagonists Product Portfolio Table 82. Chengdu Shengnuo Biology Pharmacy Recent Development Table 83. Glenmark Pharmaceuticals Company Information Table 84. Glenmark Pharmaceuticals Business Overview Table 85. Glenmark Pharmaceuticals Bradykinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Glenmark Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio Table 87. Glenmark Pharmaceuticals Recent Development Table 88. Fresenius Kabi Company Information Table 89. Fresenius Kabi Business Overview Table 90. Fresenius Kabi Bradykinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Fresenius Kabi Bradykinin Receptor Antagonists Product Portfolio Table 92. Fresenius Kabi Recent Development Table 93. Eugia Pharma Specialities Company Information Table 94. Eugia Pharma Specialities Business Overview Table 95. Eugia Pharma Specialities Bradykinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Eugia Pharma Specialities Bradykinin Receptor Antagonists Product Portfolio Table 97. Eugia Pharma Specialities Recent Development Table 98. Cipla Company Information Table 99. Cipla Business Overview Table 100. Cipla Bradykinin Receptor Antagonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Cipla Bradykinin Receptor Antagonists Product Portfolio Table 102. Cipla Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Bradykinin Receptor Antagonists Distributors List Table 106. Bradykinin Receptor Antagonists Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Bradykinin Receptor Antagonists Product Image Figure 2. Global Bradykinin Receptor Antagonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bradykinin Receptor Antagonists Market Size (2021-2032) & (US$ Million) Figure 4. Global Bradykinin Receptor Antagonists Sales (2021-2032) & (K Units) Figure 5. Global Bradykinin Receptor Antagonists Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bradykinin Receptor Antagonists Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Icatibant Image Figure 9. Other Image Figure 10. Global Bradykinin Receptor Antagonists Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Bradykinin Receptor Antagonists Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Bradykinin Receptor Antagonists Sales Market Share by Type (2021-2032) Figure 13. Global Bradykinin Receptor Antagonists Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Bradykinin Receptor Antagonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Bradykinin Receptor Antagonists Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Pharmacy Image Figure 18. Other Image Figure 19. Global Bradykinin Receptor Antagonists Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Bradykinin Receptor Antagonists Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Bradykinin Receptor Antagonists Sales Market Share by Application (2021-2032) Figure 22. Global Bradykinin Receptor Antagonists Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Bradykinin Receptor Antagonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Bradykinin Receptor Antagonists Revenue Market Share by Application (2021-2032) Figure 25. North America Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Bradykinin Receptor Antagonists Sales Market Share by Country (2021-2032) Figure 27. U.S. Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Bradykinin Receptor Antagonists Sales Market Share by Country (2021-2032) Figure 32. Germany Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Bradykinin Receptor Antagonists Sales Market Share by Country (2021-2032) Figure 39. China Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Bradykinin Receptor Antagonists Sales Market Share by Country (2021-2032) Figure 47. Brazil Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Bradykinin Receptor Antagonists Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Bradykinin Receptor Antagonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Bradykinin Receptor Antagonists Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Bradykinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Figure 58. North America Bradykinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Bradykinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Figure 60. Europe Bradykinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Bradykinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Bradykinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Bradykinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Bradykinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Bradykinin Receptor Antagonists Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Bradykinin Receptor Antagonists Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Icatibant
  • Other
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Takeda Pharmaceuticals
  • Sandoz
  • Jiangsu Hengrui Pharmaceuticals
  • Chengdu Shengnuo Biology Pharmacy
  • Glenmark Pharmaceuticals
  • Fresenius Kabi
  • Eugia Pharma Specialities
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bradykinin Receptor Antagonists Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bradykinin Receptor Antagonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bradykinin Receptor Antagonists Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bradykinin Receptor Antagonists Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bradykinin Receptor Antagonists Market Dynamics
  1. 2.1 Bradykinin Receptor Antagonists Industry Trends
  2. 2.2 Bradykinin Receptor Antagonists Industry Drivers
  3. 2.3 Bradykinin Receptor Antagonists Industry Opportunities and Challenges
  4. 2.4 Bradykinin Receptor Antagonists Industry Restraints
3 Bradykinin Receptor Antagonists Market by Manufacturers
  1. 3.1 Global Bradykinin Receptor Antagonists Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bradykinin Receptor Antagonists Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bradykinin Receptor Antagonists Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bradykinin Receptor Antagonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bradykinin Receptor Antagonists Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bradykinin Receptor Antagonists Manufacturers, Product Type & Application
  7. 3.7 Global Bradykinin Receptor Antagonists Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bradykinin Receptor Antagonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bradykinin Receptor Antagonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bradykinin Receptor Antagonists Tier 1, Tier 2, and Tier 3
4 Bradykinin Receptor Antagonists Market by Type
  1. 4.1 Bradykinin Receptor Antagonists Type Introduction
  2. 4.1.1 Icatibant
  3. 4.1.2 Other
  4. 4.2 Global Bradykinin Receptor Antagonists Sales by Type
  5. 4.2.1 Global Bradykinin Receptor Antagonists Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bradykinin Receptor Antagonists Sales by Type (2021-2032)
  7. 4.2.3 Global Bradykinin Receptor Antagonists Sales Market Share by Type (2021-2032)
  8. 4.3 Global Bradykinin Receptor Antagonists Revenue by Type
  9. 4.3.1 Global Bradykinin Receptor Antagonists Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bradykinin Receptor Antagonists Revenue by Type (2021-2032)
  11. 4.3.3 Global Bradykinin Receptor Antagonists Revenue Market Share by Type (2021-2032)
5 Bradykinin Receptor Antagonists Market by Application
  1. 5.1 Bradykinin Receptor Antagonists Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Bradykinin Receptor Antagonists Sales by Application
  6. 5.2.1 Global Bradykinin Receptor Antagonists Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bradykinin Receptor Antagonists Sales by Application (2021-2032)
  8. 5.2.3 Global Bradykinin Receptor Antagonists Sales Market Share by Application (2021-2032)
  9. 5.3 Global Bradykinin Receptor Antagonists Revenue by Application
  10. 5.3.1 Global Bradykinin Receptor Antagonists Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bradykinin Receptor Antagonists Revenue by Application (2021-2032)
  12. 5.3.3 Global Bradykinin Receptor Antagonists Revenue Market Share by Application (2021-2032)
6 Global Bradykinin Receptor Antagonists Sales by Region
  1. 6.1 Global Bradykinin Receptor Antagonists Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bradykinin Receptor Antagonists Sales by Region (2021-2032)
  3. 6.2.1 Global Bradykinin Receptor Antagonists Sales by Region (2021-2026)
  4. 6.2.2 Global Bradykinin Receptor Antagonists Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bradykinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bradykinin Receptor Antagonists Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bradykinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bradykinin Receptor Antagonists Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bradykinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bradykinin Receptor Antagonists Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bradykinin Receptor Antagonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bradykinin Receptor Antagonists Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bradykinin Receptor Antagonists Revenue by Region
  1. 7.1 Global Bradykinin Receptor Antagonists Revenue by Region
  2. 7.1.1 Global Bradykinin Receptor Antagonists Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bradykinin Receptor Antagonists Revenue by Region (2021-2026)
  4. 7.1.3 Global Bradykinin Receptor Antagonists Revenue by Region (2027-2032)
  5. 7.1.4 Global Bradykinin Receptor Antagonists Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bradykinin Receptor Antagonists Revenue (2021-2032)
  8. 7.2.2 North America Bradykinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bradykinin Receptor Antagonists Revenue (2021-2032)
  11. 7.3.2 Europe Bradykinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bradykinin Receptor Antagonists Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bradykinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bradykinin Receptor Antagonists Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bradykinin Receptor Antagonists Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceuticals
  2. 8.1.1 Takeda Pharmaceuticals Company Information
  3. 8.1.2 Takeda Pharmaceuticals Business Overview
  4. 8.1.3 Takeda Pharmaceuticals Bradykinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio
  6. 8.1.5 Takeda Pharmaceuticals Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Bradykinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Bradykinin Receptor Antagonists Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Jiangsu Hengrui Pharmaceuticals
  14. 8.3.1 Jiangsu Hengrui Pharmaceuticals Company Information
  15. 8.3.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  16. 8.3.3 Jiangsu Hengrui Pharmaceuticals Bradykinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jiangsu Hengrui Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio
  18. 8.3.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  19. 8.4 Chengdu Shengnuo Biology Pharmacy
  20. 8.4.1 Chengdu Shengnuo Biology Pharmacy Company Information
  21. 8.4.2 Chengdu Shengnuo Biology Pharmacy Business Overview
  22. 8.4.3 Chengdu Shengnuo Biology Pharmacy Bradykinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Chengdu Shengnuo Biology Pharmacy Bradykinin Receptor Antagonists Product Portfolio
  24. 8.4.5 Chengdu Shengnuo Biology Pharmacy Recent Developments
  25. 8.5 Glenmark Pharmaceuticals
  26. 8.5.1 Glenmark Pharmaceuticals Company Information
  27. 8.5.2 Glenmark Pharmaceuticals Business Overview
  28. 8.5.3 Glenmark Pharmaceuticals Bradykinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Glenmark Pharmaceuticals Bradykinin Receptor Antagonists Product Portfolio
  30. 8.5.5 Glenmark Pharmaceuticals Recent Developments
  31. 8.6 Fresenius Kabi
  32. 8.6.1 Fresenius Kabi Company Information
  33. 8.6.2 Fresenius Kabi Business Overview
  34. 8.6.3 Fresenius Kabi Bradykinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fresenius Kabi Bradykinin Receptor Antagonists Product Portfolio
  36. 8.6.5 Fresenius Kabi Recent Developments
  37. 8.7 Eugia Pharma Specialities
  38. 8.7.1 Eugia Pharma Specialities Company Information
  39. 8.7.2 Eugia Pharma Specialities Business Overview
  40. 8.7.3 Eugia Pharma Specialities Bradykinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eugia Pharma Specialities Bradykinin Receptor Antagonists Product Portfolio
  42. 8.7.5 Eugia Pharma Specialities Recent Developments
  43. 8.8 Cipla
  44. 8.8.1 Cipla Company Information
  45. 8.8.2 Cipla Business Overview
  46. 8.8.3 Cipla Bradykinin Receptor Antagonists Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cipla Bradykinin Receptor Antagonists Product Portfolio
  48. 8.8.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bradykinin Receptor Antagonists Value Chain Analysis
  2. 9.1.1 Bradykinin Receptor Antagonists Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bradykinin Receptor Antagonists Production Mode & Process
  6. 9.2 Bradykinin Receptor Antagonists Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bradykinin Receptor Antagonists Distributors
  9. 9.2.3 Bradykinin Receptor Antagonists Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst